Eurofins Scientific: share price rises, with support from an analyst
In a research note released in the morning, the British investment bank pointed out that both Q3 results and the group's recent investor day had highlighted progress on pricing and an increased focus on profit margins in Europe.
Despite the volatility of its share price, Eurofins is a sustainable and defensive company which we believe will be able to generate a total shareholder return (TSR) of around 15% over the coming years", Barclays points out.
While it reiterates its 'overweight' recommendation on the stock, the London-based bank adjusts its price target to 60 euros, from 70 euros previously.
At around 12:30 pm, the bio-analysis specialist's share price was up 0.7%, but was still down 25% since the start of the year.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction